NCT00099463View on ClinicalTrials.gov

Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS)

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 9, 2004

Study Completion Date

August 22, 2007

Conditions
Healthy
Interventions
PROCEDURE

Blood Test

PROCEDURE

Urine Test

PROCEDURE

Physical Exam

DRUG

Vaccine

DRUG

VRC-SRSDNA015-00-VP

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00099463 - Phase I Study of a Vaccine for Severe Acute Respiratory Syndrome (SARS) | Biotech Hunter | Biotech Hunter